Endovia Health Sciences, Inc. (SBEV) Form 8-K — Oct 15, 2026

$SBEVForm 8-KItems 1.01, 9.01Filed Oct 15, 2026, 4:10 PM ET0001731122-26-001347Original filing

Endovia Health Sciences entered into a letter agreement with C/M Capital Master Fund on October 15, 2026, amending its September 2025 equity line of credit purchase agreement. The amendment raises the investor's beneficial ownership limitation from 4.99% to 9.99% effective immediately, and waives notice requirements and other inconsistent provisions. Investor resales under the equity line are registered on the company's Form S-1 (File No. 333-298112), effective August 24, 2026, meaning shares can be sold into the market.

Key figures

Beneficial ownership limit new: 9.99%
Beneficial ownership limit prior: 4.99%

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.